JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $350

Benzinga Newsdesk www.benzinga.com Negative 79.3%

Neg 79.3% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.